Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Indaptus Therapeutics, Inc. (INDP) had Free Cash Flow of $-14.82M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-20.85M |
|
-- |
|
-- |
|
$19.83M |
|
$-19.83M |
|
$-1.02M |
|
$-20.85M |
|
$-20.85M |
|
$-20.85M |
|
$-20.85M |
|
$-20.85M |
|
$-20.85M |
|
$-19.83M |
|
$-19.83M |
|
0.97M |
|
0.97M |
|
$-21.58 |
|
$-21.58 |
|
| Balance Sheet Financials | |
$9.31M |
|
-- |
|
-- |
|
$9.31M |
|
$6.16M |
|
-- |
|
-- |
|
$6.16M |
|
$3.14M |
|
$3.15M |
|
$3.15M |
|
2.17M |
|
| Cash Flow Statement Financials | |
$-14.82M |
|
-- |
|
$17.54M |
|
$5.79M |
|
$8.51M |
|
$2.72M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-14.82M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-663.64% |
|
-661.54% |
|
-223.94% |
|
-661.54% |
|
$1.45 |
|
$-15.34 |
|
$-15.34 |
|